Artificial Intelligence | Machine Learning Pepgen | Transforming Treatment of Neuromuscular Diseases


Enterprise, Healthcare, Biotechnology, Pharmaceuticals, Clinical Trail Research, Drug Discovery, Neurology Cambridge, MA, United States

Pepgen

Artificial Intelligence | Machine Learning


Pepgen | Transforming Treatment of Neuromuscular Diseases

Pepgen

Healthcare, Biotechnology, Pharmaceuticals, Clinical Trail Research, Drug Discovery, Neurology


Cambridge, MA, United States

Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

PepGen is harnessing the power of our Enhanced Delivery Oligonucleotide technology to solve the challenge of getting oligonucleotides to where they need to be to work,  and to realize the clinical potential of oligonucleotide therapies to transform the lives of people living with neuromuscular diseases

 

B2B

26 to 50

Funded

$159.6 M

Scaling Up

2018

 
 

Healthcare
Biotechnology

N/A

N/A

 
 

Production
Service

Yes

Active

 
 

   Machine Learning


Biotechnology

Biotechnology


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

Dec 2021

  • PepGen Appoints Vice President of Program Management and Promotes Sonia Bracegirdle, Ph.D., to Senior Vice President, Strategy & Operations

Nov 2021

  • PepGen Bolsters R&D Team with Appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development

Oct 2021

  • PepGen Appoints Noel Donnelly as Chief Financial Officer

Oct 2021

  • PepGen Welcomes Esteemed Neurologist Dr. John Day to Scientific Advisory Board

Aug 2021

  • PepGen Announces New Additions to Leadership Team and Board of Directors
 
 

View All

View All AI/ML Jobs

Executive Assistant

Cambridge , MA

Research Associate

Cambridge , MA

Senior Scientist , Analytical Development

Cambridge , MA

Senior Director

Cambridge , MA

Research Associate -2

Cambridge , MA

 

AI/ML Professionals

Want to work at Pepgen?

We can introduce you to the right person at Pepgen

Talk to our Talent Team

 

8

1

$112.5M

Company was founded 2018 and it took almost 3 years (Aug 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

08/05/2021

Funded

$112.5M

Viking Global Investors, Tudor Investments, Samsara BioCapital, RA Capital Management, Oxford Sciences Innovation, Laurion Capital Management, Deerfield, Adage Capital Management

Date : 08/05/2021

Round: Funded

$ Raised: $112.5M

Investors: Viking Global Investors, Tudor Investments, Samsara BioCapital, RA Capital Management, Oxford Sciences Innovation, Laurion Capital Management, Deerfield, Adage Capital Management

 

Investors

Interested in researching Pepgen?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Pepgen

Request a Demo - Deal Souring Platform

 
James McArthur


James McArthur
Chief Executive Officer

Sonia Bracegirdle


Sonia Bracegirdle
SVP Strategy & Operations

Noel Donnelly


Noel Donnelly
Chief Financial Office

Niels Svenstrup


Niels Svenstrup
SVP Chemistry & Manufacturing

Caroline Godfrey


Caroline Godfrey
Senior Vice President of Discovery

Jane Larkindale


Jane Larkindale
Vice President of Clinical Science

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Pepgen